Amelioration of Human Allograft Arterial Injury by Atorvastatin or Simvastatin Correlates With Reduction of Interferon-γ Production by Infiltrating T Cells
Author(s) -
Tai Yi,
Deepak A. Rao,
Paul C. Tang,
Yig Wang,
Lisa Cuchara,
Alfred L.M. Bothwell,
Christopher M. Colangelo,
George Tellides,
Jordan S. Pober,
Marc I. Lorber
Publication year - 2008
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/tp.0b013e318183eefa
Subject(s) - atorvastatin , simvastatin , humanized mouse , arteriosclerosis , peripheral blood mononuclear cell , medicine , mycophenolate , immunology , interferon gamma , interferon , transplantation , cytokine , pharmacology , biology , in vitro , immune system , biochemistry
Graft arteriosclerosis (GA) is an important factor limiting long-term outcomes after organ transplantation. We have used a chimeric humanized mouse system to model this arteriopathy in human vessels, and found that the morphologic and functional changes of experimental GA are interferon (IFN)-gamma dependent. This study evaluated whether 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors, described as inhibitors of IFN-gamma production, affect GA in our model.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom